Tower Research Capital (TRC)’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-4,192
| Closed | -$214K | – | 6009 |
|
2024
Q4 | $214K | Buy |
4,192
+793
| +23% | +$40.5K | ﹤0.01% | 1670 |
|
2024
Q3 | $140K | Sell |
3,399
-3,430
| -50% | -$141K | ﹤0.01% | 1954 |
|
2024
Q2 | $329K | Sell |
6,829
-11,668
| -63% | -$562K | 0.01% | 1677 |
|
2024
Q1 | $887K | Buy |
18,497
+12,648
| +216% | +$607K | 0.02% | 566 |
|
2023
Q4 | $380K | Buy |
5,849
+2,538
| +77% | +$165K | ﹤0.01% | 1596 |
|
2023
Q3 | $217K | Sell |
3,311
-4,892
| -60% | -$320K | 0.01% | 1378 |
|
2023
Q2 | $477K | Buy |
8,203
+5,999
| +272% | +$349K | 0.02% | 1012 |
|
2023
Q1 | $136K | Buy |
2,204
+1,050
| +91% | +$64.8K | ﹤0.01% | 1602 |
|
2022
Q4 | $74K | Sell |
1,154
-7,926
| -87% | -$508K | ﹤0.01% | 2067 |
|
2022
Q3 | $660K | Buy |
9,080
+1,834
| +25% | +$133K | 0.01% | 928 |
|
2022
Q2 | $493K | Buy |
7,246
+5,876
| +429% | +$400K | 0.01% | 1144 |
|
2022
Q1 | $124K | Sell |
1,370
-368
| -21% | -$33.3K | ﹤0.01% | 2056 |
|
2021
Q4 | $158K | Buy |
1,738
+711
| +69% | +$64.6K | ﹤0.01% | 1939 |
|
2021
Q3 | $83K | Buy |
1,027
+342
| +50% | +$27.6K | ﹤0.01% | 2554 |
|
2021
Q2 | $64K | Sell |
685
-690
| -50% | -$64.5K | ﹤0.01% | 2815 |
|
2021
Q1 | $147K | Sell |
1,375
-1,524
| -53% | -$163K | ﹤0.01% | 2270 |
|
2020
Q4 | $253K | Buy |
2,899
+1,734
| +149% | +$151K | 0.01% | 1534 |
|
2020
Q3 | $80K | Buy |
+1,165
| New | +$80K | ﹤0.01% | 3308 |
|